GlassScriptPhysician profile
Clifton R Hamic
NPI 1245445980
$4,807.58
in general payments reported to CMS, 2019-2025
33 companies · $661 in 2025
The $661 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $584 · 2021: $1,142 · 2022: $893 · 2023: $517 · 2024: $803 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,980.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $865.15 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $598.66 | 2020-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $505.09 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $348.83 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $292.73 | 2019-2025 | Gardasil 9, Dificid, Capvaxive |
| Astellas Pharma US INC | $267.51 | 2019-2025 | Veozah |
| Amgen INC. | $258.20 | 2019-2024 | Evenity, Prolia |
| Lilly USA, LLC | $236.82 | 2020-2025 | Mounjaro, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $228.84 | 2020-2025 | Xifaxan |
| Pfizer INC. | $171.25 | 2019-2025 | |
| Dexcom, INC. | $135.08 | 2024-2025 | Dexcom G6 Transmitter |
| Allergan, INC. | $117.14 | 2020 | |
| Exact Sciences Corporation | $114.70 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $103.39 | 2020-2021 | |
| Glaxosmithkline, LLC. | $79.92 | 2019-2023 | Shingrix, Arexvy, Trelegy Ellipta |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $71.59 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $68.05 | 2020-2021 | |
| Abbott Laboratories | $48.98 | 2022 | |
| Shield Therapeutics INC | $36.20 | 2025 | |
| Sanofi-Aventis U.S. LLC | $30.06 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $28.02 | 2021 | |
| Eisai INC. | $24.50 | 2021 | |
| Horizon Therapeutics Plc | $24.20 | 2019 | |
| Phathom Pharmaceuticals, INC. | $18.90 | 2024 | Voquezna |
| Abiomed | $18.14 | 2025 | |
| Corcept Therapeutics | $17.94 | 2025 | Korlym |
| Seqirus USA INC | $16.44 | 2024 | Fluad, Flucelvax |
| Kowa Pharmaceuticals America, INC. | $15.98 | 2021 | |
| Neos Therapeutics, LP | $15.58 | 2019 | |
| Amarin Pharma, INC. | $14.53 | 2020 | |
| Idorsia Pharmaceuticals US INC | $14.52 | 2023 | Quviviq |
| Esperion Therapeutics, INC. | $14.33 | 2021 | |
| Itamar Medical INC | $6.31 | 2024 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clifton Hamic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.